Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1087-1089, March 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, S. M.
Right arrow Articles by Liskay, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, S. M.
Right arrow Articles by Liskay, R. M.

Enhanced Intestinal Adenomatous Polyp Formation in Pms2-/-;Min Mice1

Sean M. Baker, Allie C. Harris, Jen-Lan Tsao, Tom J. Flath, C. Eric Bronner, Melissa Gordon, Darryl Shibata and R. Michael Liskay2

Departments of Molecular and Medical Genetics [R. M. L., A. C. H., T. J. F., C. E. B.] and Pathology [M. G.], Oregon Health Sciences University, Portland, Oregon 97201; Department of Nutritional Sciences, University of California, Berkeley, California 94720-3104 [S. M. B.]; and Department of Pathology, University of Southern California School of Medicine, Los Angeles, California 90033 [J-L. T., D. S.]

Analysis of two human familial cancer syndromes, hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis, indicates that mutations in either one of four DNA mismatch repair gene homologues or the adenomatous polyposis coli (APC) gene, respectively, are important for the development of colorectal cancer. To further investigate the role of DNA mismatch repair in intestinal tumorigenesis, we generated mice with mutations in both Apc and the DNA mismatch repair gene, Pms2. Whereas Pms2-deficient mice do not develop intestinal tumors, mice deficient in Pms2 and heterozygous for Min, an allele of Apc, develop approximately three times the number of small intestinal adenomas and four times the number of colon adenomas relative to Min and Pms2+/-;Min mice. Although Pms2 deficiency clearly increases adenoma formation in the Min background, histological analysis indicated no clear evidence for progression to carcinoma.

1 Work performed in the laboratory of R. M. L. was supported by NIH Grants GM45413 and GM32741. Work performed in the laboratory of D. S. was supported by NIH Grants CA58704 and CA70858.

2 To whom requests for reprints should be addressed, at Department of Molecular and Medical Genetics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201. Phone: (503) 494-3475; Fax: (503) 494-6886; E-mail: liskaym@ohsu.edu.

Received 12/ 8/97. Accepted 1/29/98.




This article has been cited by other articles:


Home page
Cancer Res.Home page
O. M. Sieber, K. M. Howarth, C. Thirlwell, A. Rowan, N. Mandir, R. A. Goodlad, A. Gilkar, B. Spencer-Dene, G. Stamp, V. Johnson, et al.
Myh Deficiency Enhances Intestinal Tumorigenesis in Multiple Intestinal Neoplasia (ApcMin/+) Mice
Cancer Res., December 15, 2004; 64(24): 8876 - 8881.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
F.-M. Deng, F.-X. Liang, L. Tu, K. A. Resing, P. Hu, M. Supino, C.-C. A. Hu, G. Zhou, M. Ding, G. Kreibich, et al.
Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly
J. Cell Biol., November 25, 2002; 159(4): 685 - 694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. F. Weber, R. T. Bronson, J. Ilagan, H. Cantor, R. Schmits, and T. W. Mak
Absence of the CD44 Gene Prevents Sarcoma Metastasis
Cancer Res., April 1, 2002; 62(8): 2281 - 2286.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Qin, D. Shibata, and S. L. Gerson
Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea
Carcinogenesis, April 1, 2000; 21(4): 833 - 838.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Edelmann, A. Umar, K. Yang, J. Heyer, M. Kucherlapati, M. Lia, B. Kneitz, E. Avdievich, K. Fan, E. Wong, et al.
The DNA Mismatch Repair Genes Msh3 and Msh6 Cooperate in Intestinal Tumor Suppression
Cancer Res., February 1, 2000; 60(4): 803 - 807.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Yao, A. B. Buermeyer, L. Narayanan, D. Tran, S. M. Baker, T. A. Prolla, P. M. Glazer, R. M. Liskay, and N. Arnheim
Different mutator phenotypes in Mlh1- versus Pms2-deficient mice
PNAS, June 8, 1999; 96(12): 6850 - 6855.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Edelmann, K. Yang, M. Kuraguchi, J. Heyer, M. Lia, B. Kneitz, K. Fan, A. M. C. Brown, M. Lipkin, and R. Kucherlapati
Tumorigenesis in Mlh1 and Mlh1/Apc1638N Mutant Mice
Cancer Res., March 1, 1999; 59(6): 1301 - 1307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.